Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JGB1741 (ILS-JGB-1741) is a potent and selective inhibitor of SIRT1 with an IC50 of 15 μM. JGB1741 modulates Bax/Bcl2 ratio, cytochrome c release and PARP cleavage and increases the acetylated p53 levels leading to p53-mediated apoptosis. JGB1741 can be used in studies about breast cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 178.00 | |
10 mg | In stock | $ 297.00 | |
25 mg | In stock | $ 523.00 | |
50 mg | In stock | $ 759.00 | |
100 mg | In stock | $ 1,060.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 213.00 |
Description | JGB1741 (ILS-JGB-1741) is a potent and selective inhibitor of SIRT1 with an IC50 of 15 μM. JGB1741 modulates Bax/Bcl2 ratio, cytochrome c release and PARP cleavage and increases the acetylated p53 levels leading to p53-mediated apoptosis. JGB1741 can be used in studies about breast cancer. |
In vitro | JGB1741 (1-10000 nM) inhibits the cell proliferation of K562, HepG2 and MDA-MB 231 cell lines. JGB1741 (0.01-1 μM) induces apoptosis of MDA-MB 231 and shows a cell cycle arrest at G1 phase with more cells entering into sub G0/G1 phase. JGB1741 (0.01-1 μM) increases the global acetylation of H3K9, acetylated p53K382 levels and p53 expression[1]. |
Synonyms | ILS-JGB-1741 |
Molecular Weight | 440.56 |
Formula | C27H24N2O2S |
CAS No. | 1256375-38-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.41 mg/mL (10 mM), Sonification is recommended
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JGB1741 1256375-38-8 Chromatin/Epigenetic DNA Damage/DNA Repair Sirtuin ILS-JGB 1741 ILS-JGB-1741 JGB 1741 ILS-JGB1741 JGB-1741 inhibitor inhibit